Your Good Partner in Biology Research

  1. 首页
  2. 蛋白
  3. 重组蛋白
  4. Recombinant Human Sodium bicarbonate transporter-like protein 11 (SLC4A11), partial

Recombinant Human Sodium bicarbonate transporter-like protein 11 (SLC4A11), partial

  • 中文名称：
    人SLC4A11重组蛋白
  • 货号：
    CSB-YP818756HU
  • 规格：
  • 来源：
    Yeast
  • 其他：
  • 中文名称：
    人SLC4A11重组蛋白
  • 货号：
    CSB-EP818756HU
  • 规格：
  • 来源：
    E.coli
  • 其他：
  • 中文名称：
    人SLC4A11重组蛋白
  • 货号：
    CSB-EP818756HU-B
  • 规格：
  • 来源：
    E.coli
  • 共轭：
    Avi-tag Biotinylated

    E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.

  • 其他：
  • 中文名称：
    人SLC4A11重组蛋白
  • 货号：
    CSB-BP818756HU
  • 规格：
  • 来源：
    Baculovirus
  • 其他：
  • 中文名称：
    人SLC4A11重组蛋白
  • 货号：
    CSB-MP818756HU
  • 规格：
  • 来源：
    Mammalian cell
  • 其他：

产品详情

  • 纯度：
    >85% (SDS-PAGE)
  • 基因名：
    SLC4A11
  • Uniprot No.：
  • 别名：
    Bicarbonate transporter related protein 1; Bicarbonate transporter-related protein 1; BTR1; CDPD; CHED2; Corneal endothelial dystrophy 2 autosomal recessive; dJ794I6.2; FECD4; MGC126418; MGC126419; NaBC1; S4A11_HUMAN; Slc4a11; Sodium bicarbonate transporter-like protein 11; Sodium borate cotransporter 1; Sodium coupled borate cotransporter 1; Solute carrier family 4 member 11; Solute carrier family 4 sodium bicarbonate transporter like member 11; Solute carrier family 4 sodium borate transporter member 11
  • 种属：
    Homo sapiens (Human)
  • 蛋白长度：
    Partial
  • 蛋白标签：
    Tag type will be determined during the manufacturing process.
    The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
  • 产品提供形式：
    Lyophilized powder
    Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
  • 复溶：
    We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
  • 储存条件：
    Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
  • 保质期：
    The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
    Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
  • 货期：
    Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
    Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
  • 注意事项：
    Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
  • Datasheet ：
    Please contact us to get it.

产品评价

靶点详情

  • 功能：
    Multifunctional transporter with an impact in cell morphology and differentiation. In the presence of borate B(OH)4(-), acts as a voltage-dependent electrogenic Na(+)-coupled B(OH)4(-) cotransporter controlling boron homeostasis. At early stages of stem cell differentiation, participates in synergy with ITGA5-ITGB1 and ITGAV-ITGB3 integrins and BMPR1A to promote cell adhesion and contractility that drives differentiation toward osteogenic commitment while inhibiting adipogenesis. In the absence of B(OH)4(-), acts as a Na(+)-coupled OH(-) or H(+) permeable channel with implications in cellular redox balance. Regulates the oxidative stress response in corneal endothelium by enhancing antioxidant defenses and protecting cells from reactive oxygen species. In response to hypo-osmotic challenge, also acts as water permeable channel at the basolateral cell membrane of corneal endothelial cells and facilitates transendothelial fluid reabsorption in the aqueous humor. In the presence of ammonia, acts as an electrogenic NH3/H(+) cotransporter and may play a role in ammonia transport and reabsorption in renal Henle's loop epithelium.
  • 基因功能参考文献：
    1. Based on these findings, we infer that high SLC4A11 expression is an independent predictor for poor OS in grade 3/4 serous ovarian cancer. Both DNA amplification and hypomethylation contribute to its upregulation in ovarian cancer PMID: 29091960
    2. A missense SLC4A11 mutation (Leu843Pro) is responsible for CHED2 in this family; this is the first report of this mutation in a homozygous state. PMID: 27057589
    3. for the first time, compound heterozygous SLC4A11 mutations impair protein function leading to delayed onset of the disease. PMID: 27609159
    4. These complex ion transport properties need to be addressed in the context of corneal endothelial disease processes caused by mutations in SLC4A11. PMID: 27581649
    5. A role of human SLC4A11 in bicarbonate or borate transport. PMID: 27558157
    6. Slc4a11 is an ideally selective H(+)/OH(-) conductive pathway. PMID: 27681179
    7. SLC4A11 rs3810560 polymorphism independently affected the sustained viral response rates in chronic hepatitis C patients treated with PEGIFN2b/ribavirin/combination. PMID: 26750805
    8. Analysis of SLC4A11, ZEB1, LOXHD1, COL8A2 and TCF4 gene sequences in a multi-generational family with late-onset Fuchs corneal dystrophy found no evidence for found polymorophisms causing the disease in this specific pedigree. PMID: 27121161
    9. study reports a newly identified mutation (c.2024A>C) in the SLC4A11 gene segregating with the diseased haplotype in two consanguineous Pakistani families PMID: 26286922
    10. we report posterior polymorphous corneal dystrophy resulting from a de novo mutation in ZEB1. Additionally, we present a congenital hereditary endothelial dystrophy case with a thin Descemet membrane with a novel compound heterozygous SLC4A11 mutation. PMID: 26619383
    11. we review the current knowledge on the role of the SLC4A11 gene, protein, and its mutations in the pathophysiology and clinical presentation of CHED. [review] PMID: 26451371
    12. We report a novel nonsense mutation of the SLC4A11 gene in the patient with CHED2. In addition, one of heterozygous carriers in this family showed features of late onset Fuchs endothelial corneal dystrophy. PMID: 24502824
    13. SLC4A11 mutations contribute to 11% (5/45) of sporadic late-onset Late-onset Fuchs endothelial corneal dystrophy (FECD) in the cohort studied. PMID: 25007886
    14. SLC4A11 is a novel NH3/H+ co-transporter. PMID: 26018076
    15. We found that cells containing mutant SLC4A11 are more vulnerable to oxidative and mitochondrial damage, less able to overcome oxidative stress through the expression of sufficient levels of antioxidant genes, and are more prone to apoptotic death. PMID: 25811729
    16. In contrast to the Slc4a11(-/-) mouse, no abnormalities in daily renal ion excretion or polyuria were observed in the Harboyan syndrome patient. PMID: 25500497
    17. Potential therapeutic agents to improve the functional impairment of specific SLC4A11 mutant transporters. PMID: 25394471
    18. We have described three affected siblings from a non-consanguineous family with Corneal Endothelial Dystrophy 2. PMID: 25138764
    19. Our observations suggest that congenital hereditary endothelial dystrophy caused by homozygous SLC4A11 mutations progresses to Harboyan syndrome, but the severity of this may vary considerably. PMID: 24351571
    20. Variation in the COL8A2, SLC4A11, and ZEB1 genes is present in only a small fraction of African American cases and as such does not appear to significantly contribute to the genetic risk of Fuchs endothelial corneal dystrophy. PMID: 24348007
    21. Data shows that the function of SLCA11 is to facilitate the movement of water across the basolateral corneal epithelium. PMID: 23813972
    22. To the best of our knowledge, this is the first Korean case of CHED2, confirmed by the c.1239C>A (p.C413*) mutation in the SLC4A11 gene, which has not been previously reported. PMID: 23615275
    23. SLC4A11 has significant EIPA-sensitive Na(+)-OH(-)(H(+)) and NH4(+) permeability. PMID: 23864606
    24. The purpose of this study was to identify the genetic cause of congenital hereditary endothelial dystrophy 2 in six Indian families and catalog all known mutations in the SLC4A11 gene. PMID: 23922488
    25. Both substitution c.214+242C > T in IL1RN and novel deletion c.2558+149_2558+203del54 in SLC4A11 were observed significantly more frequently in family members with keratoconus. PMID: 23462747
    26. SLC4A11 is necessary for cell survival and may explain the pathologic corneal endothelial cell loss in endotheliopathies due to SLC4A11 mutations. PMID: 22447871
    27. The reduction in movement of WT SLC4A11 protein to the cell surface caused by Fuchs endothelial corneal dystrophy SLC4A11 helps to explain the dominant inheritance of this disorder. PMID: 22072594
    28. biochemical study of SLC4A11 PMID: 21288032
    29. The present study detected one novel and three reported changes, adding to the repertoire of mutations in SLC4A11, and recorded a high degree of genetic heterogeneity in Congenital Hereditary Endothelial Dystrophy. PMID: 21203343
    30. sequenced SLC4A11 in 192 sporadic and small nuclear late-onset Fuchs corneal dystrophy families and found seven heterozygous missense novel variations that were absent from ethnically matched controls PMID: 20848555
    31. Corneal endothelial cells are more vulnerable to defects in the functional activity of SLC4A11 than cells of the striae vascularis of the inner ear. PMID: 20118786
    32. The corneal dystrophy and perceptive deafness (Harboyan syndrome) gene (CDPD1) maps to chromosome 20p13. PMID: 11836359
    33. describe seven different mutations in the SLC4A11 gene in ten families with autosomal recessive congenital hereditary endothelial dystrophy PMID: 16767101
    34. These results confirm that mutations in the SLC4A11 gene cause autosomal recessive corneal endothelial dystrophy. PMID: 16825429
    35. These findings extend the implication of the SLC4A11 borate transporter beyond corneal dystrophy to perceptive deafness. PMID: 17220209
    36. Novel indel mutation, c.859_862delGAGAinsCCT (E287fsX21) in exon 8 of SLC4A11 gene. Novel in-frame deletion mutation c.2014_2016delTTC or 2017_2019delTTC which will lead to loss of a phenylalanine residue at position 672 or 673 (F672del or F673del). PMID: 17262014
    37. report of seven novel mutations and two previously identified mutations in families from India and the United Kingdom with recessive congenital hereditary endothelial dystrophy PMID: 17397048
    38. CHED2 (congenital hereditary endothelial dystrophy) is associated with mutations in SLC4A11, a member of the SLC4 family of base transporters. PMID: 17667634
    39. These data add to the mutational repertoire of SLC4A11 and establish the high degree of mutational heterogeneity in autosomal recessive congenital hereditary endothelial dystrophy. PMID: 17679935
    40. SLC4A11 mutations in Fuchs' endothelial corneal dystrophy are reported. PMID: 18024964
    41. A novel SLC4A11 mutation (Thr271Met) is associated with autosomal recessive congenital hereditary endothelial dystrophy in a pedigree from the Kingdom of Saudi Arabia and provides additional support that mutations in this gene cause disease. PMID: 18363173
    42. This study increases the number of SLC4A11 gene mutations and confirms the role of this gene in causing congenital hereditary endothelial dystrophy (CHED2). PMID: 18474783
    43. In this small cohort, no evidence was found of genetic heterogeneity in congenital hereditary endothelial dystrophy (CHED) and that loss of BTR1 function is the most likely mutational mechanism. PMID: 19369245

    显示更多

    收起更多

  • 相关疾病：
    Corneal dystrophy and perceptive deafness (CDPD); Corneal endothelial dystrophy (CHED); Corneal dystrophy, Fuchs endothelial, 4 (FECD4)
  • 亚细胞定位：
    Cell membrane; Multi-pass membrane protein. Basolateral cell membrane; Multi-pass membrane protein.
  • 蛋白家族：
    Anion exchanger (TC 2.A.31) family
  • 组织特异性：
    Widely expressed. Highly expressed in kidney, testis, salivary gland, thyroid, trachea and corneal endothelium. Not detected in retina and lymphocytes.; [Isoform 3]: Expressed in corneal endothelium (at protein level).; [Isoform 5]: The predominant isofor
  • 数据库链接：

    HGNC: 16438

    OMIM: 217400

    KEGG: hsa:83959

    STRING: 9606.ENSP00000369399

    UniGene: Hs.105607